Altimmune [ALT] vs Cg Oncology [CGON] Detailed Comparison
Altimmune
NASDAQ
Loading...
Cg Oncology
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 11 vital metrics comparison: Altimmune wins in 1 metrics, Cg Oncology wins in 9 metrics, with 1 ties. Cg Oncology appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Altimmune | Cg Oncology | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -3.18 | -18.06 | Cg Oncology |
| Price-to-Book Ratio | 2.33 | 2.80 | Altimmune |
| Debt-to-Equity Ratio | 1.12 | 0.15 | Cg Oncology |
| PEG Ratio | -2.90 | -14.55 | Cg Oncology |
| EV/EBITDA | -1.69 | -9.64 | Cg Oncology |
| Profit Margin | 0.00% | 0.00% | Tie |
| Operating Margin | -436,300.00% | -81,161.54% | Cg Oncology |
| Return on Equity | -57.28% | -16.58% | Cg Oncology |
| Return on Assets | -35.51% | -12.85% | Cg Oncology |
| Free Cash Flow | $-79.85M | $-78.95M | Cg Oncology |
| 1-Year Return | -33.44% | -29.16% | Cg Oncology |
Overview
Performance
Valuation
Financials
Short Interest
Dividends
Altimmune vs Cg Oncology Price History Comparison
Loading Price Chart...
Key Statistics Comparison
Loading Statistics...
Performance
Altimmune vs Cg Oncology Performance Comparison Chart
Loading Price Chart...
Performance Comparison
Loading Performance Data...
Short-term Returns
Long-term Returns
Valuation
Valuation History
Loading Valuation History...
Market Capitalization % Change
P/E Ratio (TTM)
Forward P/E
PEG Ratio
Price to Sales (TTM)
Price to Book (MRQ)
Enterprise Value % Change
EV/EBITDA
EV/Revenue
Valuation Metrics
Loading Valuation Metrics...
Financials
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement Comparison (TTM)
Loading Financials...
Income Statement (MRQ)
Balance Sheet & Liquidity Metrics (MRQ)
Cash Flow Statement Comparison (MRQ)
Short Interest And Ownership
Short Interest And Ownership Metrics
Loading Short Interest And Ownership Data...
Dividends
Dividend Information
Loading Dividend Information...